Combination with reserved prognosis: TB- rheumatoid arthritis

1. Rheumatoid arthritis and tuberculosis: Time to take notice. Gardam M, Iverson K. s.l. : The Journal of Rheumatology, 2003, Vol. 30:7, pp. 1397–1399. Gardam M Iverson K. s.l. : Rheumatoid arthritis and tuberculosis: Time to take notice . The Journal of Rheumatology , 2003 , Vol. 30 : 7 , pp. 1397 – 1399 . Search in Google Scholar

2. Tuberculosis comorbidity with rheumatoid arthritis: Gene signatures, associated biomarkers and screening. Zafari P, Golpour M, Hafezi N, Bashash D, Esmaeili S.A, Tavakolinia N et al. s.l. : IUBMB Life, 2021, Vol. 73, pp. 26–39. Zafari P Golpour M Hafezi N Bashash D Esmaeili S.A Tavakolinia N s.l. : Tuberculosis comorbidity with rheumatoid arthritis: Gene signatures, associated biomarkers and screening . IUBMB Life , 2021 , Vol. 73 , pp. 26 – 39 . Search in Google Scholar

3. Risk of tuberculosis reactivation in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis receiving non anti-TNF-targeted biologics. Cantini F, Nannini C, Niccoli L, Petrone L, Ippolito G, Goletti D. s.l. : Hindawi-Mediators of inflammation, 2017, pp. 1–15. Cantini F Nannini C Niccoli L Petrone L Ippolito G Goletti D. s.l. : Risk of tuberculosis reactivation in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis receiving non anti-TNF-targeted biologics . Hindawi-Mediators of inflammation , 2017 , pp. 1 – 15 . Search in Google Scholar

4. Methotrexate and reactivation tuberculosis. S.R, Lamb. s.l. : Journal of the American Academi of Dermatology, 2004, Vol. 51, pp. 481–482. Lamb S.R . s.l. : Methotrexate and reactivation tuberculosis . Journal of the American Academi of Dermatology , 2004 , Vol. 51 , pp. 481 – 482 . Search in Google Scholar

5. Leflunomide-associated tuberculosis? Hocevar A, Rozman B, Praprotnik S, Lestan B, Erzen D, Petric V et al. s.l. : Rheumatology-Letters to the Editor, 2006, Vol. 45, pp. 228–229. Hocevar A Rozman B Praprotnik S Lestan B Erzen D Petric V s.l. : Leflunomide-associated tuberculosis? Rheumatology-Letters to the Editor , 2006 , Vol. 45 , pp. 228 – 229 . Search in Google Scholar

6. Latent tuberculosis infection in RA: The disease and the diagnosis. Metha B, Efthimiou P. s.l. : The journal of musculoskeletal medicine, 2011, Vol. 28. Metha B Efthimiou P. s.l. : Latent tuberculosis infection in RA: The disease and the diagnosis . The journal of musculoskeletal medicine , 2011 , Vol. 28 . Search in Google Scholar

7. Antirheumatic drugs and the risk of tuberculosis. Brassard P, Kezouh A, Suissa S. s.l. : Clinical Infectious Diseases, 2006, Vol. 43, pp. 717–722. Brassard P Kezouh A Suissa S. s.l. : Antirheumatic drugs and the risk of tuberculosis . Clinical Infectious Diseases , 2006 , Vol. 43 , pp. 717 – 722 . Search in Google Scholar

8. Miliary tuberculosis in a rheumatoid arthritis patient receiving long-term tumor necrosis factor monoclonal antibody therapy. Wang C.R, Lin W.C, Tsai Y.S. 2021, Vol. 27, pp. 364–366. Wang C.R Lin W.C Tsai Y.S. 2021 , Miliary tuberculosis in a rheumatoid arthritis patient receiving long-term tumor necrosis factor monoclonal antibody therapy . Vol. 27 , pp. 364 – 366 . Search in Google Scholar

9. Safety analyses of adalimumab in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis. Schiff M.H, Burmester G.R, Kent J.D, Pagan A.L, Kupper H, Fitzpatrick S.B et al. s.l. : Annals of Rheumatic diseases, 2006, Vol. 65, pp. 889–894. Schiff M. H, Burmester G. R, Kent J. D, Pagan A. L, Kupper H Fitzpatrick S.B s.l. : Safety analyses of adalimumab in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis . Annals of Rheumatic diseases , 2006 , Vol. 65 , pp. 889 – 894 . Search in Google Scholar

10. Miliary Tuberculosis. Vohra S, Dhaliwal HS. s.l. : StatPearls Publishing, Treasure Island, 2022. Vohra S Dhaliwal HS. s.l. : Miliary Tuberculosis . StatPearls Publishing , Treasure Island , 2022 . Search in Google Scholar